Where scientists, regulators and industry move together to create change.
Who we are
The Heart & Valve Collaboratory is a public-private partnership with the FDA. We are a patient-centered, cross-disciplinary community of physician-scientists, clinical leaders, industry partners, and MedTech innovators.
Our work
Working groups
H&VC working groups bring multidisciplinary experts together to address important topics, develop consensus documents and other actionable outputs that help advance research, policy, and patient outcomes.
Working group
A global group of leading experts working to advance knowledge and share best practices in the prevention and treatment of rheumatic heart disease.
Explore the group
Working group
A number of ongoing efforts to build knowledge, develop consensus, and ignite innovation in congenital, adult congenital, and pediatric heart disease.
Explore the group
Working group
This working group is addressing the evolving landscape of clinical trial conduct in the modern era through proof-of-concept projects, publications, and more.
Explore the group
Resources
Recently released
Podcasts, publications and trainings from the Collaboratory.
Podcast · 22 min
Video · 22 min
Congenital and Pediatric Heart Disease
Bioprosthetic Valve Durability: A Multi-Disciplinary Approach
Martin Leon, Philippe Pibarot, and Ajit Yoganathan discuss the evolving understanding of bioprosthetic valve failure, the challenges of tissue deterioration, and the need for improved testing and collaboration to enhance valve longevity, especially for younger patients.
Podcast · 21 min
Video · 21 min
Rheumatic Heart Disease
Initiatives of the World Heart Federation to Fight Rheumatic Heart Disease
Ami Bhatt and Jagat Narula discuss the World Heart Federation's initiatives to combat Rheumatic Heart Disease and other neglected cardiovascular diseases, advocating for research, government action, and primary care for early detection.